file_qzk26aw6u5adxdbotsubtmkeay

Associated Releases

2022-09-22

Dose of approved COVID-19 vaccines is based on weak evidence: a review of early-phase, dose-finding trials
unknown status | post
doi:10.1101/2022.09.20.22276701

Public Access URLs

repository	`https://www.medrxiv.org/content/medrxiv/early/2022/09/22/2022.09.20.22276701.full.pdf`
webarchive	`https://web.archive.org/web/20220927015330/https://www.medrxiv.org/content/medrxiv/early/2022/09/22/2022.09.20.22276701.full.pdf`

Data Integrity Checksums

SHA-1	`7bb8fcbc5aefb302394fc2c3ccb954fc892b62f0`
SHA-256	`d6ccd9ec3f061da96524f0710148130434b6e8a73b7d23d86fd0e303d63fbc46`
MD5	`63dc539a7e38141f2770ed751c84b5c7`

View Archived File

Size 250.7 kB
MIME Type application/pdf

Catalog Record
Revision: 9492ed68-6999-4b36-8a61-c7e6c3a07266
API URL: JSON

Edit Metadata View History